https://www.selleckchem.com/pr....oducts/skf-34288-hyd
Three months after treatment, Ocular Surface Disease Index showed a significant reduction in 95.6% (P 0.0001), tear breakup time increased in 72.3% (P 0.0001), and meibomian gland expressibility scoring increased in 80.8% (P 0.0001) of the eyes. These effects were observed to be sustained during the 6-month follow-up visit. Significant (P 0.05) reduction in tear fluid levels of interleukin-1β, interleukin-17F, and MMP9; MMP9/TIMP1 ratio; and ocular surface B-cell proportions was observed. Combined lig
Like
Comment
Share
